Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BL, Schumacher B, Rembacken B, Meining A, Messmann H, Schoon EJ, Gossner L, Mannath J, Seldenrijk CA, Visser M, Lerut T, Seewald S, ten Kate FJ, Ell C, Neuhaus H, Bergman JJ. Phoa KN, et al. Among authors: visser m. Gut. 2016 Apr;65(4):555-62. doi: 10.1136/gutjnl-2015-309298. Epub 2015 Mar 2. Gut. 2016. PMID: 25731874
Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG, Alvarez Herrero L, Pouw RE, Schrijnders D, Sondermeijer CM, Bisschops R, Esteban JM, Meining A, Neuhaus H, Parra-Blanco A, Pech O, Ragunath K, Rembacken B, Schenk BE, Visser M, ten Kate FJ, Meijer SL, Reitsma JB, Weusten BL, Schoon EJ, Bergman JJ. van Vilsteren FG, et al. Among authors: visser m. Endoscopy. 2013 Jul;45(7):516-25. doi: 10.1055/s-0032-1326423. Epub 2013 Apr 11. Endoscopy. 2013. PMID: 23580412 Clinical Trial.
The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patients.
Duits LC, Klaver E, Bureo Gonzalez A, Boerwinkel DF, Ten Kate FJW, Offerhaus GJA, Meijer SL, Visser M, Seldenrijk CA, Krishnadath KK, Schoon EJ, Weusten BLAM, Mallant-Hent RC, Pouw RE, Bergman JJGHM. Duits LC, et al. Among authors: visser m. Dis Esophagus. 2019 Nov 13;32(9):doy037. doi: 10.1093/dote/doy037. Dis Esophagus. 2019. PMID: 29873685
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.
Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro M, Ravi N, Visser M, Offerhaus GJ, Seldenrijk CA, Meijer SL, ten Kate FJ, Tijssen JG, Bergman JJ. Phoa KN, et al. Among authors: visser m. JAMA. 2014 Mar 26;311(12):1209-17. doi: 10.1001/jama.2014.2511. JAMA. 2014. PMID: 24668102 Clinical Trial.
The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.
di Pietro M, Boerwinkel DF, Shariff MK, Liu X, Telakis E, Lao-Sirieix P, Walker E, Couch G, Mills L, Nuckcheddy-Grant T, Slininger S, O'Donovan M, Visser M, Meijer SL, Kaye PV, Wernisch L, Ragunath K, Bergman JJ, Fitzgerald RC. di Pietro M, et al. Among authors: visser m. Gut. 2015 Jan;64(1):49-56. doi: 10.1136/gutjnl-2013-305975. Epub 2014 Apr 10. Gut. 2015. PMID: 24721904 Free PMC article.
2,189 results